Skip to main content
. Author manuscript; available in PMC: 2013 Apr 17.
Published in final edited form as: ACS Med Chem Lett. 2012 Nov 29;4(1):57–62. doi: 10.1021/ml300275g

Table 2.

Experimental and predicted anti-proliferative activity of analogues derived from 2

SKBr3 (μM) Predicted (μM) MCF-7 (μM)
16 1.41±0.20a 0.99 1.58±0.09
17 1.40± 0.07 1.63 1.44± 0.05
18 1.40± 0.11 0.73 1.12± 0.16
19 0.60±0.01 0.58 1.25±0.39
20 3.46±0.02 1.74 5.01±0.01
21a 2.26±0.12 2.00 2.00±0.18
21b 1.67±0.20 1.42 1.62±0.04
21c 1.68±0.12 1.83 2.10±0.08
21d 11.5± 2.0 2.90 11.7±1.0
21e 3.50±0.01 0.97 1.61±0.16
22a 2.43±0.04 1.15 2.17±0.11
22b 0.84±0.18 0.96 1.43±0.08
22e 2.30±0.57 0.33 1.48±0.14
a

Values represent mean ± standard deviation for at least two separate experiments performed in triplicate.